1: \begin{abstract}

2: Despite the availability of large amounts of genomics data, medical

3: treatment recommendations have not successfully used them.

4: In this paper, we consider the utility of high dimensional 

5: genomic-clinical data and nonparametric methods for making cancer treatment

6: recommendations. This builds upon the framework of the individualized  

7: treatment rule \cite{Qian11} but we aim to overcome their method's

8: limitations, specifically in the instances when the method encounters

9: a large number of covariates  

10: and an issue of model misspecification. We tackle this problem using a

11: dimension reduction method, namely Sliced Inverse Regression (SIR, \cite{Li91}),

12: with a rich class of models for the treatment response. Notably,

13: SIR defines a feature space for high-dimensional data,

14: offering an advantage similar to those found in the popular 

15: neural network models. With the features obtained from SIR, a simple

16: visualization is used to compare 

17: different treatment options and present the recommended

18: treatment. Additionally, we derive the  

19: consistency and the convergence rate of the

20: proposed recommendation approach through a value function. 

21: The effectiveness of the proposed approach is demonstrated through

22: simulation studies and the promising results from a real-data example

23: of the treatment of multiple myeloma.

24: \end{abstract}

25: